1. MiMedx Adds Luis A. Aguilar To Its Board Of Directors

    MiMedx Adds Luis A. Aguilar To Its Board Of Directors

    MiMedx Group, Inc., the leading regenerative medicine and biopharmaceutical company utilizing human placental tissue allografts and patent-protected processes to develop and market advanced products and therapies for multiple sectors of healthcare, announced today its Board of Directors has appointed Luis A. Aguilar, former Commissioner of the U.S. Securities and Exchange Commission and highly accomplished lawyer within industry and private law practice, as an independent, non-employee Director of the MiMedx Board of Directors...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content

    1. We are very pleased to have Luis on our Board and look forward to the superb insight and additional perspectives that he will offer to our executives, Board of Directors and Company.
  3. Topics Mentioned